China
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 452.25 B
|
Dec. 31, 2023 | USD 0.55 | 0.68% |
|
China |
|
2 |
USD 424.10 B
|
Dec. 31, 2023 | USD 0.81 | 0.62% |
|
China |
|
3 |
USD 319.10 B
|
Dec. 31, 2023 | USD 0.76 | 1.47% |
|
China |
|
4 |
USD 177.96 B
|
Dec. 31, 2023 | USD 0.47 | 2.48% |
|
China |
|
5 |
USD 160.29 B
|
Dec. 31, 2023 | USD 0.69 | 1.86% |
|
China |
|
6 |
USD 152.77 B
|
Dec. 31, 2023 | USD 17.45 | 5.32% |
|
China |
|
7 |
USD 130.30 B
|
March 31, 2024 | USD 10.26 | 2.34% |
|
China |
|
8 |
USD 112.97 B
|
Dec. 31, 2023 | USD 5.31 | 1.07% |
|
China |
|
9 |
USD 107.56 B
|
Dec. 31, 2023 | USD 1.33 | 2.20% |
|
China |
|
10 |
USD 106.43 B
|
Dec. 31, 2023 | USD 0.65 | 2.18% |
|
China |
|
11 |
USD 104.89 B
|
Dec. 31, 2023 | USD 2.32 | 4.80% |
|
China |
|
12 |
USD 103.50 B
|
Dec. 31, 2023 | USD 1.70 | 2.13% |
|
China |
|
13 |
USD 92.53 B
|
Dec. 31, 2023 | USD 0.63 | 0.60% |
|
China |
|
14 |
USD 89.28 B
|
Dec. 31, 2023 | USD 0.20 | 3.35% |
|
China |
|
15 |
USD 87.66 B
|
Dec. 31, 2023 | USD 0.77 | 1.51% |
|
China |
|
16 |
USD 85.84 B
|
Dec. 31, 2023 | USD 0.69 | 2.03% |
|
China |
|
17 |
USD 85.78 B
|
Dec. 31, 2023 | USD 48.14 | 2.44% |
|
China |
|
18 |
USD 84.84 B
|
Dec. 31, 2023 | USD 32.99 | 3.11% |
|
China |
|
19 |
USD 84.03 B
|
Dec. 31, 2023 | USD 2.59 | 1.33% |
|
China |
|
20 |
USD 81.62 B
|
Dec. 31, 2023 | USD 0.65 | 2.60% |
|
China |
|
21 |
USD 78.84 B
|
Dec. 31, 2023 | USD 0.54 | 0.46% |
|
China |
|
22 |
USD 73.51 B
|
Dec. 31, 2023 | USD 1.64 | 0.13% |
|
China |
|
23 |
USD 73.00 B
|
Dec. 31, 2023 | USD 0.49 | 0.51% |
|
China |
|
24 |
USD 70.67 B
|
Dec. 31, 2023 | USD 0.47 | 2.19% |
|
China |
|
25 |
USD 67.09 B
|
Dec. 31, 2023 | USD 2.80 | 4.32% |
|
China |
|
26 |
USD 65.95 B
|
Dec. 31, 2023 | USD 0.86 | 2.11% |
|
China |
|
27 |
USD 65.60 B
|
Dec. 31, 2023 | USD 0.64 | 2.88% |
|
China |
|
28 |
USD 64.66 B
|
Dec. 31, 2023 | USD 0.85 | 5.05% |
|
China |
|
29 |
USD 62.37 B
|
Dec. 31, 2023 | USD 0.92 | 2.25% |
|
China |
|
30 |
USD 62.00 B
|
Dec. 31, 2023 | USD 1.54 | 1.84% |
|
China |
|
31 |
USD 57.19 B
|
Dec. 31, 2023 | USD 0.12 | 3.27% |
|
China |
|
32 |
USD 56.47 B
|
Dec. 31, 2023 | USD 34.94 | 3.77% |
|
China |
|
33 |
USD 52.48 B
|
Dec. 31, 2023 | USD 0.66 | 2.33% |
|
China |
|
34 |
USD 52.40 B
|
Dec. 31, 2023 | USD 10.18 | 0.44% |
|
China |
|
35 |
USD 49.72 B
|
Dec. 31, 2023 | USD 0.27 | 3.15% |
|
China |
|
36 |
USD 48.86 B
|
Dec. 31, 2023 | USD 1.20 | 1.63% |
|
China |
|
37 |
USD 48.57 B
|
Dec. 31, 2023 | USD 0.90 | 1.08% |
|
China |
|
38 |
USD 48.32 B
|
Dec. 31, 2023 | USD 3.96 | 1.29% |
|
China |
|
39 |
USD 45.79 B
|
Dec. 31, 2023 | USD 1.22 | 2.53% |
|
China |
|
40 |
USD 45.68 B
|
Dec. 31, 2023 | USD 2.88 | 2.72% |
|
China |
|
41 |
USD 44.61 B
|
Dec. 31, 2023 | USD 0.57 | 0.43% |
|
China |
|
42 |
USD 42.91 B
|
Dec. 31, 2023 | USD 0.34 | 2.89% |
|
China |
|
43 |
USD 41.95 B
|
Dec. 31, 2023 | USD 5.12 | 4.29% |
|
China |
|
44 |
USD 41.33 B
|
Dec. 31, 2023 | USD 1.97 | 0.37% |
|
China |
|
45 |
USD 38.98 B
|
Dec. 31, 2023 | USD 18.52 | 5.00% |
|
China |
|
46 |
USD 38.17 B
|
Dec. 31, 2023 | USD 4.33 | 2.87% |
|
China |
|
47 |
USD 36.82 B
|
Dec. 31, 2023 | USD 3.23 | 2.42% |
|
China |
|
48 |
USD 36.66 B
|
Dec. 31, 2023 | USD 1.58 | 1.46% |
|
China |
|
49 |
USD 35.83 B
|
Dec. 31, 2023 | USD 0.51 | 2.04% |
|
China |
|
50 |
USD 35.43 B
|
Dec. 31, 2023 | USD 4.24 | 2.01% |
|
China |
The company in China with the highest Revenue is China Petroleum & Chemical Corporation (HKSE: 0386.HK) at USD 452.25 B.
The company in China with the lowest Revenue is Connect Biopharma Holdings Limited (NasdaqGM: CNTB) at USD 0.00.
The top 10 companies in China by Revenue are China Petroleum & Chemical Corporation, PetroChina Company Limited, China State Construction Engineering Corporation Limited, China Railway Group Limited, China Railway Construction Corporation Limited, JD.com, Inc., Alibaba Group Holding Limited, Ping An Insurance (Group) Company of China, Ltd., Xiamen C&D Inc. and China Communications Construction Company Limited.
The bottom 10 companies in China by Revenue are Connect Biopharma Holdings Limited, GD Culture Group Limited, HighTide Therapeutics Inc, Genor Biopharma Holdings Limited, Shanghai Bio-heart Biological Technology Co., Ltd., ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Sentage Holdings Inc., Infobird Co., Ltd, Mercurity Fintech Holding Inc. and MMTec, Inc..